News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AVEO Pharmaceuticals, Inc. to Utilize Peptech Limited's Breakthrough Technology to ''Humanise'' Internal Drug Candidates


10/2/2007 10:02:16 AM

CAMBRIDGE, Mass. & SYDNEY, Australia--(BUSINESS WIRE)--Peptech Limited (ASX: PTD) and AVEO Pharmaceuticals Inc. today announced they have entered into a non-exclusive research and commercialisation agreement in which AVEO will access Peptech’s SuperhumanisationTM technology to humanise internally-derived drug candidates.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES